SPI-8811 AND SPI-017 EXCLUSIVE CLINICAL MANUFACTURING AND SUPPLY AGREEMENTExclusive Clinical Manufacturing and Supply Agreement • October 25th, 2006 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 25th, 2006 Company Industry JurisdictionTHIS SPI-8811 AND SPI-017 EXCLUSIVE CLINICAL MANUFACTURING AND SUPPLY AGREEMENT (“Agreement”) is made as of this 4th day of October 2006 (the “Signing Date”), by and among Sucampo Pharmaceuticals, Inc., a corporation organized and existing under the laws of the state of Delaware, U.S.A. and having its principal office at 4733 Bethesda Avenue, Suite 450, Bethesda, Maryland 20814, U.S.A. (“SPI”), and R-Tech Ueno, Ltd., a corporation organized and existing under the laws of Japan and having its registered office at 10F, Yamato Life Insurance Bldg., 1-1-7 Uchisaiwaicho, Chiyoda-ku, Tokyo, Japan 100-0011 (“RTU”) (each referred to herein as a “Party” and collectively as the “Parties”).